8-K Filing

Company

Alzamend Neuro, Inc.

Filed

July 9, 2025

Period of Report

July 9, 2025

Accession Number

0001214659-25-010209

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →